BICO : Carcinotech and CELLINK Enter a Partnership to Develop and Commercialize Protocols for Cancer Models to Provide Improved Speed and Accuracy in the Drug Development Processes -October 04, 2023 at 11:43 pm EDT
Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK's bioprinting solutions and Carcinotech's expertise in producing 3D bioprinted living tumors to...